Stocksigma LogoStocksigma Logo

Accretion Pharma Board Approves Key Financial and Structural Changes

Accretion Pharmaceuticals' board, on 1st Sep'26, approved key proposals subject to shareholder consent

Accretion Pharma Board Approves Key Financial and Structural Changes

Accretion Pharmaceuticals Ltd 路 Others (Uncategorized) 路 01 Sept 2026, 7:16 pm

Accretion Pharma Board Approves Key Financial and Structural Changes Accretion Pharmaceuticals' board, on 1st Sep'26, approved key proposals subject to shareholder consent. These include altering the MOA's object clause to expand business activities and raising borrowing limits under Section 180(1)(c). The board also approved enhancing limits for creating charges on assets under Section 180(1)(a). Additionally, proposals were passed for advancing loans/guarantees to related parties and exceeding prescribed limits for loans, guarantees, and investments. All approvals are contingent on a forthcoming postal ballot for shareholder ratification.

Original exchange filing (PDF)

More announcements from Accretion Pharmaceuticals Ltd

All Accretion Pharmaceuticals Ltd announcements